On CNBC’s "Mad Money Lightning Round," Jim Cramer said CRISPR Therapeutics AG (NASDAQ:CRSP) is likely to "lose a lot of money. But more importantly, this is the kind of company right now that is so out of favor that, unless you are willing to take a beating, which I do not encourage, I think you have to take a pass on it,"
With American Airlines Group Inc. (NASDAQ:AAL) losing a lot of money, Cramer is not recommending stocks that are losing a lot of money unless they can return to profitability "within the next year, at least."
